HealthCare Market Analysis

The global  antifungal drugs market  was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key contributing factor for the growth of the antifungal drugs market in the coming years. Rising adoption of immunosuppressive andantineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics have resulted in the increasing incidence of fungal infections in the recent years.  Global Antifungal Drugs Market Revenue, By Drug Class, 2014 - 2025 (USD Million) The growing geriatric population prone to infectious diseases and higher prevalence of chronic conditions, including HIV and cancer, are further contributing toward the rising demand for antifungals to treat opportunistic fungal infections over the forecast period. The large demand for these fungistatic agents is due to the nature of fungal infections, which are difficult to diagnose, ...

The global   blood pressure monitoring devices market  is expected to reach USD 2.0 billion by 2022, according to a new report by Grand View Research, Inc. Rising geriatric population prone to high blood pressure is expected to widen the consumer base by triggering incidences of target diseases such as hypertension which is anticipated to drive the demand for blood pressure monitors in the future. In addition, increasing awareness levels and demand for personalized & portable devices for monitoring are the factors contributing towards the market growth. North America blood pressure monitoring devices market, by product, 2012-2022 (USD Million) Increasing incidence of hypertension has led to rising demand for cost effective, rapid and accurate diagnostic solutions. Blood pressure monitors are one of the vital sign monitor of life. The cost effective and accurate results offer by these indicators is the factor responsible for the market growth. Browse full...

The global  microelectronic medical implants market  size is anticipated to reach USD 57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth.  Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017. Increasing prevalence of diseases such as epilepsy, cardiac di...